Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
Ontology highlight
ABSTRACT: Recombinant antibodies such as nanobodies are progressively demonstrating to be a valid alternative to conventional monoclonal antibodies also for clinical applications. Furthermore, they do not solely represent a substitute for monoclonal antibodies but their unique features allow expanding the applications of biotherapeutics and changes the pattern of disease treatment. Nanobodies possess the double advantage of being small and simple to engineer. This combination has promoted extremely diversified approaches to design nanobody-based constructs suitable for particular applications. Both the format geometry possibilities and the functionalization strategies have been widely explored to provide macromolecules with better efficacy with respect to single nanobodies or their combination. Nano
SUBMITTER: Wang J
PROVIDER: S-EPMC8804282 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA